NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 155 filers reported holding NEKTAR THERAPEUTICS in Q1 2015. The put-call ratio across all filers is 0.53 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $618,000 | -87.7% | 26,700 | -67.5% | 0.06% | -89.3% |
| Q3 2018 | $5,015,000 | +39.5% | 82,263 | +11.7% | 0.53% | +32.3% |
| Q2 2018 | $3,595,000 | -65.8% | 73,614 | -25.6% | 0.40% | -65.1% |
| Q1 2018 | $10,511,000 | +49.4% | 98,914 | -16.0% | 1.15% | +31.1% |
| Q4 2017 | $7,036,000 | +3920.6% | 117,815 | +823.3% | 0.88% | +10887.5% |
| Q1 2016 | $175,000 | -92.4% | 12,760 | -90.7% | 0.01% | -91.9% |
| Q4 2015 | $2,311,000 | +102.0% | 137,127 | +31.3% | 0.10% | +90.4% |
| Q3 2015 | $1,144,000 | -8.4% | 104,399 | +4.6% | 0.05% | 0.0% |
| Q2 2015 | $1,249,000 | +43.6% | 99,852 | +26.2% | 0.05% | +57.6% |
| Q1 2015 | $870,000 | – | 79,115 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rhenman & Partners Asset Management AB | 1,350,000 | $22,950,000 | 1.87% |
| MAVERICK CAPITAL LTD | 6,655,625 | $113,146,000 | 1.81% |
| Camber Capital Management LP | 2,500,000 | $42,500,000 | 1.49% |
| Bellevue Group AG | 3,866,258 | $65,726,000 | 0.75% |
| Adero Partners, LLC | 51,500 | $876,000 | 0.75% |
| Goodman Financial Corp | 108,342 | $1,842,000 | 0.64% |
| CM Management, LLC | 35,000 | $595,000 | 0.55% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 424,504 | $7,217,000 | 0.43% |
| RICE HALL JAMES & ASSOCIATES, LLC | 568,379 | $9,662,000 | 0.34% |
| Burleson & Company, LLC | 107,736 | $1,832,000 | 0.32% |